Suppr超能文献

基于人群的绝经后妇女队列中肝脂肪变性的种族/民族差异:密歇根妇女健康全国研究。

Racial/ethnic differences in hepatic steatosis in a population-based cohort of post-menopausal women: the Michigan Study of Women's Health Across the Nation.

机构信息

Department of Medicine, Ann Arbor, MI, USA; Department of Obstetrics and Gynecology, Ann Arbor, MI, USA.

出版信息

Diabet Med. 2013 Dec;30(12):1433-41. doi: 10.1111/dme.12225. Epub 2013 Jun 7.

Abstract

AIMS

The prevalence of hepatic steatosis may differ between post-menopausal African-American women and non-Hispanic white women and by sex hormone binding globulin level. We examined prevalence of hepatic steatosis by race/ethnicity and associations with sex hormone binding globulin.

METHODS

Participants included post-menopausal women who underwent hepatic ultrasound (n = 345) at the Michigan site of the Study of Women's Health Across the Nation, a population-based study. We examined hepatic steatosis prevalence by race/ethnicity and used logistic regression models to calculate the odds of hepatic steatosis with race/ethnicity and sex hormone binding globulin, after adjustment for age, alcohol use, waist circumference, high density lipoprotein cholesterol, triglycerides, systolic blood pressure and use of medications reported to lower intrahepatic fat.

RESULTS

Fewer African-American women than non-Hispanic white women had hepatic steatosis (23 vs. 36%, P = 0.01). African-American women had lower triglyceride and low-density lipoprotein cholesterol levels, but higher blood pressure and follicle-stimulating hormone levels (P < 0.05). In the optimal-fitting multivariable models, women in the highest tertile of sex hormone binding globulin (60.2-220.3 nmol/l) had a lower odds of hepatic steatosis (odds ratio 0.43, 95% CI 0.20-0.93) compared with women in the lowest tertile of sex hormone binding globulin (10.5-40.3 nmol/l). There was an interaction between race/ethnicity and medication use whereby non-Hispanic white women using medications had three times higher odds of hepatic steatosis compared with African-American women not using medications (odds ratio 3.36, 95% CI 1.07-10.58). Interactions between race/ethnicity and other variables, including sex hormone levels, were not significant.

CONCLUSIONS

Hepatic steatosis on ultrasound may be more common in post-menopausal non-Hispanic white women than African-American women and was associated with lower levels of sex hormone binding globulin.

摘要

目的

绝经后非裔美国女性和非西班牙裔白种女性的肝脂肪变性患病率可能不同,且与性激素结合球蛋白水平有关。我们通过种族/民族检查肝脂肪变性的患病率,并检查其与性激素结合球蛋白的相关性。

方法

参与者为参加全国妇女健康研究密歇根站点的绝经后女性,该研究为基于人群的研究,对这些女性进行了肝脏超声检查(n=345)。我们通过种族/民族检查肝脂肪变性的患病率,并使用逻辑回归模型计算在调整年龄、饮酒、腰围、高密度脂蛋白胆固醇、甘油三酯、收缩压和报告用于降低肝内脂肪的药物使用后,肝脂肪变性与种族/民族和性激素结合球蛋白的比值比。

结果

非裔美国女性中肝脂肪变性的比例低于非西班牙裔白种女性(23%比36%,P=0.01)。非裔美国女性的甘油三酯和低密度脂蛋白胆固醇水平较低,但血压和促卵泡激素水平较高(P<0.05)。在最佳拟合的多变量模型中,性激素结合球蛋白最高三分位组(60.2-220.3 nmol/L)的女性肝脂肪变性的可能性较低(比值比 0.43,95%CI 0.20-0.93)与性激素结合球蛋白最低三分位组(10.5-40.3 nmol/L)的女性相比。种族/民族与药物使用之间存在交互作用,即使用药物的非西班牙裔白种女性与不使用药物的非裔美国女性相比,肝脂肪变性的可能性高 3 倍(比值比 3.36,95%CI 1.07-10.58)。种族/民族与其他变量(包括性激素水平)之间的相互作用不显著。

结论

绝经后非西班牙裔白种女性的超声肝脂肪变性可能比非裔美国女性更为常见,且与较低的性激素结合球蛋白水平有关。

相似文献

2
Racial differences in body composition and cardiometabolic risk during the menopause transition: a prospective, observational cohort study.
Am J Obstet Gynecol. 2020 Apr;222(4):365.e1-365.e18. doi: 10.1016/j.ajog.2019.09.051. Epub 2019 Oct 11.
5
Reproductive history and chronic hepatic steatosis in the Michigan Study of Women's Health Across the Nation.
J Womens Health (Larchmt). 2015 Jan;24(1):42-8. doi: 10.1089/jwh.2014.4839. Epub 2014 Dec 30.
7
Sex Steroid Hormones and Fracture in a Multiethnic Cohort of Women: The Women's Health Initiative Study (WHI).
J Clin Endocrinol Metab. 2017 May 1;102(5):1538-1547. doi: 10.1210/jc.2016-3589.
8

引用本文的文献

3
Racial Disparities in Diagnosis and Prognosis of Nonalcoholic Fatty Liver Disease.
Clin Liver Dis (Hoboken). 2020 Sep 4;16(2):66-72. doi: 10.1002/cld.948. eCollection 2020 Aug.
5
A Systematic Review of Beta Cell Function in Adults of Black African Ethnicity.
J Diabetes Res. 2019 Oct 20;2019:7891359. doi: 10.1155/2019/7891359. eCollection 2019.
7
Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.
World J Gastroenterol. 2015 Feb 7;21(5):1650-62. doi: 10.3748/wjg.v21.i5.1650.
8
Reproductive history and chronic hepatic steatosis in the Michigan Study of Women's Health Across the Nation.
J Womens Health (Larchmt). 2015 Jan;24(1):42-8. doi: 10.1089/jwh.2014.4839. Epub 2014 Dec 30.

本文引用的文献

1
Role of sex steroids, intrahepatic fat and liver enzymes in the association between SHBG and metabolic features.
Clin Endocrinol (Oxf). 2013 Oct;79(4):517-22. doi: 10.1111/cen.12089. Epub 2013 Apr 13.
3
Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes.
Diabetes Care. 2012 Apr;35(4):717-22. doi: 10.2337/dc11-1853. Epub 2012 Feb 14.
6
Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes.
Diabetes Res Clin Pract. 2011 Oct;94(1):156-62. doi: 10.1016/j.diabres.2011.07.029. Epub 2011 Sep 8.
9
10
Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome.
J Clin Endocrinol Metab. 2011 Mar;96(3):799-807. doi: 10.1210/jc.2010-1608. Epub 2010 Dec 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验